Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Fonar Corp.

Fonar Corp. (FONR) Stock Overview

Explore Fonar Corp.’s financial performance, market position, analyst ratings, and future outlook.

FONR●NASDAQ
HealthcareMedical - Equipment & Services
$19.09
$0.00(0.00%)
U.S. Market opens in 49h 50m

Fonar Corp. (FONR)

Meyka AI Score

Z

Key Financials

Market Cap117.8M
P/E Ratio18.90
EPS (TTM)$1.00
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$25.05
1 Year Target$18.16

FONR Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Fonar Corp. (NASDAQ: FONR) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Fonar Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FONR on the NASDAQ shows an RSI of 77.74, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $18.16 for the NASDAQ listing.

Key metrics behind Fonar Corp.'s NASDAQ-traded stock include a P/E ratio of 18.90 and a market capitalization of 117.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FONR on the NASDAQ.

Price Performance (NASDAQ: FONR)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
2.63%
6-Month Change
3.13%
Year-to-Date (YTD) Change
2.86%
1-Year Change
23.48%
3-Year Change
12.69%
5-Year Change
12.16%
All-Time (Max) Change
-84.09%

Contact Information

https://www.fonar.com
631 694 2929
110 Marcus Drive, Melville, NY, 11747

Company Facts

5,330 Employees
IPO DateOct 29, 1981
CountryUS

Frequently Asked Questions